MedDataX Logo

Nutritional Study of Fish Oil in Skin Quality in Healthy Women

NCT ID: NCT05128240

Last Updated: 2021-11-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-08-23

Study Completion Date

2022-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The skin acts as a barrier against the external environment and prevents water loss from the body. Aging is a natural process leading to changes in the skin and fish oil has been shown to prevent inflammation, hyperpigmentation and UV-damage. This pilot study will determine skin characteristics after intervention with north atlantic fish oil.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Women will be recruited to a placebo or fish oil group and be examined at pre- and post for skin quality parameters such as wrinkles, fine lines and trans-epithelial water loss.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Skin Health

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

skin inflammation wrinkles trans epithelial water loss fish oil LCMUFA

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Placebo controlled, double blind intervention study.
Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors
Interventions are given as 1g bovine capsules of equal size, weight and appearance, and provided in identical bottles with a coded label.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Placebo

4x1g corn oil capsules

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DIETARY_SUPPLEMENT

1g corn oil capsules

Ceto 10

4x1g capsules containing containing broad spectrum marine oil from north atlantic fish

Group Type EXPERIMENTAL

Ceto 10

Intervention Type DIETARY_SUPPLEMENT

1g capsules containing oil broad spectrum marine oil from north atlantic fish

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Placebo

1g corn oil capsules

Intervention Type DIETARY_SUPPLEMENT

Ceto 10

1g capsules containing oil broad spectrum marine oil from north atlantic fish

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Healthy women in the age of 30-65

Able to follow the following dietary restriction for 4 months (4 weeks wash-out, 3 months intervention):

* Do not take omega-3 supplements
* do not take supplements containing vitamin A
* do not take supplements containing collagen
* try to avoid using skin products containing vitamin A
* do not undergo skin treatment

Exclusion Criteria

Pregnancy or breast feeding known allergy to seafood skin treatment the last 6 months planned skin treatment during the study period

\-
Minimum Eligible Age

30 Years

Maximum Eligible Age

65 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Møreforsking AS

OTHER

Sponsor Role collaborator

Epax Norway AS

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lisa Midtbø, PhD

Role: PRINCIPAL_INVESTIGATOR

Møreforsking AS

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Møreforsking AS

Ålesund, , Norway

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Norway

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Derek Tobin, PhD

Role: CONTACT

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Lise Midtbø, PhD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P237921

Identifier Type: -

Identifier Source: org_study_id